查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828235

2025年结构性心臟全球市场报告

Structural Heart Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，结构性心臟病市场规模强劲成长，从2024年的149亿美元成长到2025年的158.9亿美元，复合年增长率为6.6%。预测期内的成长可归因于认知度和筛检的提高、供应链的韧性、医疗支出的增加、市场集中度的提升以及人们对心血管疾病认识的不断提高。

预计未来几年结构性心臟市场规模将强劲成长，到2029年将达到224.8亿美元，复合年增长率为9.1%。预测期内的成长归因于心臟瓣膜装置的需求、人口老化、心血管疾病负担的增加、市场区隔以及区域市场的成长。预测期内的主要趋势包括产品发布、技术进步、经济復苏、监管收紧、心血管疾病负担的增加以及创新医疗设备。

结构性心臟病学是循环系统的一个分支学科，致力于诊断和治疗心臟结构性异常和疾病，特别是影响瓣膜、心室和周围结构的疾病。此领域通常涉及在导管室进行的微创手术，而非传统的开胸手术。

结构性心臟产品的主要类别包括封堵器、环状成形术环、心臟瓣膜球囊和其他相关设备。封堵器专门设计用于提供导管，以便将设备输送到心腔、冠状动脉和周边血管。这些设备用于治疗某些类型的心房中膈缺损症（特征是右心房或心室扩大），以防止异常栓塞。使用结构性心臟产品的各种手术包括治疗心臟瓣膜狭窄、心臟瓣膜逆流和左心耳阻塞。这些手术面向各种最终用户，包括医院、门诊手术中心和心臟中心。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供结构性心臟市场统计数据，例如结构性心臟行业的全球市场规模、区域份额、结构性心臟市场份额的竞争对手、详细的结构性心臟市场细分、市场趋势和机会，以及您在结构性心臟行业取得成功所需的数据。这份结构性心臟市场研究报告对该行业的现状和未来走势进行了详细分析，为您提供所需的一切资讯的完整观点。

我们预测未来五年该市场将成长9.1%，较先前预测略有下降0.2%。下降的主要原因是美国与其他国家之间关税的影响。这种影响可能会直接波及美国，导致经导管瓣膜和输送系统等关键部件的供应链中断，这些部件来自爱尔兰、德国和哥斯达黎加等主要地区，可能导致治疗延误和手术成本增加。此外，这种影响还可能透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，更广泛地体现出来。

预计心血管疾病的增加将在未来几年推动结构性心臟市场的成长。心血管疾病包括影响心臟和血管的疾病，例如冠状动脉疾病，心臟衰竭和中风。心血管疾病盛行率的增加主要是由于人口老化，生活方式和饮食习惯的改变以及肥胖和糖尿病发病率上升等因素。结构性心臟设备和服务在影响心臟瓣膜，心室和周围组织的异常和疾病的诊断和治疗中起着关键作用。采用微创手术取代开心手术可以实现更有效的治疗并减少併发症的风险。例如，根据美国心臟病学会于 2022 年 8 月发布的一份报告，预计 2025 年至 2060 年间美国所有四种心血管风险因素都将增加，其中糖尿病患者预计将达到 5500 万，增长 39.3％。

肥胖趋势预计将促进结构性心臟市场扩张。肥胖是一种以体内脂肪过度堆积为特征的疾病，会导致身体质量指数 (BMI) 达到或超过 30，并增加心血管疾病的风险。全球肥胖症的流行推动了对先进结构性心臟干预措施的需求，以应对肥胖导致的心血管风险增加。世界肥胖联合会 2022 年 5 月的报告指出，到 2030 年，全球将有 10 亿人患有肥胖症，其中包括五分之一的女性和七分之一的男性；预计到 2035 年，这一数字将增至 40 亿，占全球人口的 51%。因此，肥胖盛行率的上升对结构性心臟市场的成长产生了重大影响。

技术进步已成为推动结构性心臟病市场发展的突出趋势。主要市场参与企业正专注于开发创新产品以巩固其市场地位。例如，2023 年 2 月，美国数位健康公司 Eko Health 推出了 SENSORA，这是一个心臟病检测平台，利用人工智慧在基层医疗中进行非侵入性心臟病检测。 SENSORA 使用数位听诊器捕捉和分析心音和电讯号，识别结构性杂音（心臟瓣膜疾病的征兆），并支持关键决策。该技术透过减少治疗延迟、住院时间和再入院率来提高营运效率，有助于提高患者和医生的满意度。

结构性心臟市场的主要参与企业正在创新先进产品，例如经导管边缘到边缘修復 (TEER) 系统，以改善心臟瓣膜疾病的微创治疗选择。 TEER 系统是一种旨在治疗心臟瓣膜疾病，特别是瓣膜闭锁不全的微创医疗设备。例如，2024 年 4 月，美国医疗设备公司雅培实验室的一种名为 TriClip 的设备获得了美国食品药物管理局(FDA) 的核准， 美国联邦机构。 TriClip 是一种透过腿部静脉插入的创新 TEER 系统，即使对于因年龄或已有疾病而处于高风险的患者，也无需进行开心手术即可进行瓣膜修復。该设备使用夹子抓住并连接三尖瓣小叶，减少逆流并改善血流。

2022年2月，总部位于新加坡的医疗科技公司Genesis MedTech收购了美国结构性心臟病公司JC Medical (JCM)，收购金额未揭露。此次收购将增强Genesis MedTech的产品系列，推出微创经导管主动脉瓣置换术(TAVR)装置J-Valve，为结构性心臟病提供全面的解决方案，从而巩固其市场地位。

结构性心臟市场由提供患者评估、诊断、治疗计划、外科手术或介入治疗以及后续后续观察等服务的营业单位所获得的收益构成。市场规模还包括服务提供者销售的或包含在其服务产品中的相关产品的价值。结构性心臟市场还包括经导管心臟瓣膜、封堵器以及手术过程中使用的植入式器械的销售。该市场的价值是指“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 世界的结构核心：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球结构性心臟市场：成长率分析
  • 全球结构性心臟市场表现：规模与成长，2019-2024
  • 全球结构性心臟市场预测：2024-2029年、2034年规模与成长
  • 全球结构性心臟：总目标市场（TAM）

第六章 市场细分

  • 全球结构性心臟市场（依产品、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 封堵器
  • 环状成形术环
  • 心臟瓣膜球囊
  • 其他的
  • 全球结构性心臟市场（依手术程序、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 心臟瓣膜狭窄
  • 心臟瓣膜逆流
  • 左心耳封堵术
  • 全球结构性心臟市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 心臟中心
  • 全球结构性心臟市场：封堵器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 心房间隔缺损 (ASD) 封堵器
  • 卵圆孔未闭合（PFO）封堵器
  • 室间隔缺损 (VSD) 封堵器
  • 全球结构性心臟市场：环状成形术术环细分，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 硬质环状成形术环
  • 软环状成形术圈
  • 可调式环状成形术环
  • 全球结构性心臟市场：心臟瓣膜球囊细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 球囊扩张心臟瓣膜系统
  • 瓣环成形球囊
  • 全球结构性心臟市场：其他细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 经导管心臟瓣膜
  • 结构性心臟影像设备
  • 结构性心臟手术系统

第七章 区域和国家分析

  • 全球结构性心臟市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球结构性心臟市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 结构性心臟市场：竞争格局
  • 结构性心臟市场：公司简介
    • Abbott
    • Medtronic plc
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • Trane Technologies

第31章：其他领先和创新企业

  • Lepu Medical Technology Co. Ltd.
  • LivaNova PLC
  • Biomerics LLC
  • Venus Medtech（Hangzhou）Inc.
  • Cryolife Inc.
  • Endologix Inc.
  • Shockwave Medica Inc.
  • Braile Biomedica
  • JenaValve Technology Inc.
  • Corvia Medical Inc
  • HLT Medical
  • On-X Life Technologies Inc.
  • Symetis SA
  • Magenta Therapeutics
  • PASCAL Medical

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年结构性心臟市场：提供新机会的国家
  • 2029年结构性心臟市场：细分领域带来新机会
  • 2029年结构性心臟市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25335u

Structural heart is a subspecialty within cardiology that concentrates on diagnosing and treating structural abnormalities or diseases of the heart, particularly those impacting the valves, chambers, and surrounding structures. This field typically involves minimally invasive procedures conducted in a catheterization laboratory as opposed to traditional open-heart surgery.

The primary categories of structural heart products encompass occluders, annuloplasty rings, heart valve balloons, and other related devices. Occluder systems are specifically designed to provide a conduit for delivering devices into the heart's chambers, coronary arteries, and peripheral vasculature. These devices are utilized in patients with specific types of atrial septal defects featuring right atrial or ventricle enlargement, preventing paradoxical embolism. The diverse procedures employing structural heart products include heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. These procedures cater to various end-users such as hospitals, ambulatory surgical centers, and cardiac centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The structural heart market research report is one of a series of new reports from The Business Research Company that provides structural heart market statistics, including structural heart industry global market size, regional shares, competitors with a structural heart market share, detailed structural heart market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart industry. This structural heart market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The structural heart market size has grown strongly in recent years. It will grow from $14.9 billion in 2024 to $15.89 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased awareness and screening, supply chain resilience, increasing healthcare expenditure, market concentration, and increasing awareness of cardiovascular diseases.

The structural heart market size is expected to see strong growth in the next few years. It will grow to $22.48 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to the demand for heart valve devices, aging population, growing burden of cardiovascular diseases, market segmentation, regional market growth. Major trends in the forecast period include product launches, technological advancements, economic recovery, regulatory impositions, rising incidences of cardiovascular diseases, and innovative medical devices.

The forecast of 9.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for critical components like transcatheter valves and delivery systems, sourced from key regions such as Ireland, Germany, and Costa Rica, which could lead to treatment delays and increased procedure costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in cardiovascular disorders is expected to drive the growth of the structural heart market in the future. Cardiovascular disorders encompass diseases affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The increasing prevalence of cardiovascular disorders is primarily attributed to factors such as the aging population, shifts in lifestyle and diet, and escalating rates of obesity and diabetes. Structural heart devices and services play a crucial role in diagnosing and treating anomalies or disorders affecting the valves, chambers, and surrounding tissues of the heart, employing minimally invasive procedures instead of open-heart surgery to ensure efficient treatment with lower-risk complications. For example, a report published by the American College of Cardiology in August 2022 highlighted the projected increase in all four cardiovascular risk factors in the United States between 2025 and 2060, with diabetes expected to see a 39.3% rise to 55 million individuals, underscoring the significant role of cardiovascular disorders in propelling the structural heart market's growth.

The upward trend in obesity rates is anticipated to contribute to the expansion of the structural heart market. Obesity, characterized by excessive body fat accumulation resulting in a body mass index (BMI) of 30 or higher, is a medical condition associated with heightened cardiovascular challenges. The persistent global obesity epidemic drives the demand for advanced structural heart interventions to address the increased cardiovascular risks linked to obesity. As indicated by a report from the World Obesity Federation in May 2022, it is projected that by 2030, one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity, and this number is expected to increase to 4 billion people or 51% of the global population by 2035. Thus, the escalating rates of obesity are instrumental in steering the growth of the structural heart market.

Technological advancements have emerged as a prominent trend gaining traction in the structural heart market. Leading market players are channeling their efforts into creating innovative products to strengthen their market position. For instance, in February 2023, Eko Health, a US-based digital health company, introduced the SENSORA cardiac disease detection platform, utilizing artificial intelligence for non-invasive heart disease detection in primary care. SENSORA features digital stethoscopes to capture and analyze heart sounds and electrical signals, aiding in key decision-making by identifying structural murmurs, a sign of valvular heart disease. This technology enhances operational efficiency by reducing delays in care delivery, length of stay, and readmission rates, contributing to both patient and physician satisfaction.

Key players in the structural heart market are innovating advanced products, including transcatheter edge-to-edge repair (TEER) systems, to improve minimally invasive treatment options for heart valve diseases. TEER systems are minimally invasive medical devices designed to address heart valve conditions, particularly mitral valve regurgitation. For example, in April 2024, Abbott Laboratories, a US-based medical device firm, gained approval from the Food and Drug Administration (FDA), a US federal agency responsible for safeguarding public health, for its device called TriClip. TriClip is an innovative TEER system that is delivered through a vein in the leg, allowing for valve repair without the need for open-heart surgery, making it suitable for patients who might be at greater risk due to age or pre-existing health conditions. The device operates by using clips to grasp and bring together the leaflets of the tricuspid valve, thereby decreasing regurgitation and enhancing blood flow.

In February 2022, Genesis MedTech, a Singapore-based medical technology company, acquired JC Medical (JCM), a US-based company operating in the structural heart market, for an undisclosed amount. This acquisition enables Genesis MedTech to enhance its product portfolio with J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device, reinforcing its position in the market by offering comprehensive solutions for structural heart disease.

Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomedica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q'Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the structural heart market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The structural heart market consists of revenues earned by entities by providing services such as patient evaluation, diagnosis, treatment planning, surgical or interventional procedures, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The structural heart market also includes sales of transcatheter heart valves, closure devices, and implantable devices that are used during procedures. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Structural Heart Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on structural heart market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for structural heart ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The structural heart market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Occluders; Annuloplasty Rings; Heart Valve Balloons; Other Products
  • 2) By Procedure: Heart Valve Stenosis; Heart Valve Regurgitation; Left Atrial Appendage Closure
  • 3) By End Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Subsegments:
  • 1) By Occluders: Atrial Septal Defect (ASD) Occluders; Patent Foramen Ovale (PFO) Occluders; Ventricular Septal Defect (VSD) Occluders
  • 2) By Annuloplasty Rings: Rigid Annuloplasty Rings; Flexible Annuloplasty Rings; Adjustable Annuloplasty Rings
  • 3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems; Valvuloplasty Balloons
  • 4) By Other Products: Transcatheter Heart Valves; Structural Heart Imaging Devices; Delivery Systems For Structural Heart Procedures
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Edwards Lifesciences Corporation; Trane Technologies; Lepu Medical Technology Co. Ltd.; LivaNova PLC; Biomerics LLC; Venus Medtech (Hangzhou) Inc.; Cryolife Inc.; Endologix Inc.; Shockwave Medica Inc.; Braile Biomedica; JenaValve Technology Inc.; Corvia Medical Inc; HLT Medical; On-X Life Technologies Inc.; Symetis SA; Magenta Therapeutics; PASCAL Medical; Micro Interventional Devices Inc.; CardioKinetix Inc; Tendyne Holdings Inc.; Q'Apel Medical Inc.; Neovasc Inc.; NVT AG; Z-Medical GmbH + Co. KG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Structural Heart Market Characteristics

3. Structural Heart Market Trends And Strategies

4. Structural Heart Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Structural Heart Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Structural Heart PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Structural Heart Market Growth Rate Analysis
  • 5.4. Global Structural Heart Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Structural Heart Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Structural Heart Total Addressable Market (TAM)

6. Structural Heart Market Segmentation

  • 6.1. Global Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Occluders
  • Annuloplasty Rings
  • Heart Valve Balloons
  • Other Products
  • 6.2. Global Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Heart Valve Stenosis
  • Heart Valve Regurgitation
  • Left Atrial Appendage Closure
  • 6.3. Global Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
  • 6.4. Global Structural Heart Market, Sub-Segmentation Of Occluders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect (ASD) Occluders
  • Patent Foramen Ovale (PFO) Occluders
  • Ventricular Septal Defect (VSD) Occluders
  • 6.5. Global Structural Heart Market, Sub-Segmentation Of Annuloplasty Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rigid Annuloplasty Rings
  • Flexible Annuloplasty Rings
  • Adjustable Annuloplasty Rings
  • 6.6. Global Structural Heart Market, Sub-Segmentation Of Heart Valve Balloons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Expandable Heart Valve Systems
  • Valvuloplasty Balloons
  • 6.7. Global Structural Heart Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Heart Valves
  • Structural Heart Imaging Devices
  • Delivery Systems For Structural Heart Procedures

7. Structural Heart Market Regional And Country Analysis

  • 7.1. Global Structural Heart Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Structural Heart Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Structural Heart Market

  • 8.1. Asia-Pacific Structural Heart Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Structural Heart Market

  • 9.1. China Structural Heart Market Overview
  • 9.2. China Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Structural Heart Market

  • 10.1. India Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Structural Heart Market

  • 11.1. Japan Structural Heart Market Overview
  • 11.2. Japan Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Structural Heart Market

  • 12.1. Australia Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Structural Heart Market

  • 13.1. Indonesia Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Structural Heart Market

  • 14.1. South Korea Structural Heart Market Overview
  • 14.2. South Korea Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Structural Heart Market

  • 15.1. Western Europe Structural Heart Market Overview
  • 15.2. Western Europe Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Structural Heart Market

  • 16.1. UK Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Structural Heart Market

  • 17.1. Germany Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Structural Heart Market

  • 18.1. France Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Structural Heart Market

  • 19.1. Italy Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Structural Heart Market

  • 20.1. Spain Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Structural Heart Market

  • 21.1. Eastern Europe Structural Heart Market Overview
  • 21.2. Eastern Europe Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Structural Heart Market

  • 22.1. Russia Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Structural Heart Market

  • 23.1. North America Structural Heart Market Overview
  • 23.2. North America Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Structural Heart Market

  • 24.1. USA Structural Heart Market Overview
  • 24.2. USA Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Structural Heart Market

  • 25.1. Canada Structural Heart Market Overview
  • 25.2. Canada Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Structural Heart Market

  • 26.1. South America Structural Heart Market Overview
  • 26.2. South America Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Structural Heart Market

  • 27.1. Brazil Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Structural Heart Market

  • 28.1. Middle East Structural Heart Market Overview
  • 28.2. Middle East Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Structural Heart Market

  • 29.1. Africa Structural Heart Market Overview
  • 29.2. Africa Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Structural Heart Market Competitive Landscape And Company Profiles

  • 30.1. Structural Heart Market Competitive Landscape
  • 30.2. Structural Heart Market Company Profiles
    • 30.2.1. Abbott Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Trane Technologies Overview, Products and Services, Strategy and Financial Analysis

31. Structural Heart Market Other Major And Innovative Companies

  • 31.1. Lepu Medical Technology Co. Ltd.
  • 31.2. LivaNova PLC
  • 31.3. Biomerics LLC
  • 31.4. Venus Medtech (Hangzhou) Inc.
  • 31.5. Cryolife Inc.
  • 31.6. Endologix Inc.
  • 31.7. Shockwave Medica Inc.
  • 31.8. Braile Biomedica
  • 31.9. JenaValve Technology Inc.
  • 31.10. Corvia Medical Inc
  • 31.11. HLT Medical
  • 31.12. On-X Life Technologies Inc.
  • 31.13. Symetis SA
  • 31.14. Magenta Therapeutics
  • 31.15. PASCAL Medical

32. Global Structural Heart Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Structural Heart Market

34. Recent Developments In The Structural Heart Market

35. Structural Heart Market High Potential Countries, Segments and Strategies

  • 35.1 Structural Heart Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Structural Heart Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Structural Heart Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer